AML

Boehringer Ingelheim to initiate Phase III study in leukemia with its compound volasertib* based on positive Phase II results
Pipeline Review
Tue, 12/11/12 - 11:31 am
Boehringer Ingelheim
leukemia
volasertib
AML
acute myeloid leukemia
Upcoming AML Treatments - Which Company Will Fly?
Seeking Alpha
Mon, 12/3/12 - 10:49 am
AML
Celgene
Cyclacel
Sunesis
acute myeloid leukemia
An ASCO Bio-Pharma Catalyst Trade With A Promising Leukemia Drug
Seeking Alpha
Wed, 05/9/12 - 10:19 am
leukemia
ASCO
Sunesis
Bristol-Myers Squibb
vosaroxin
Ariad Pharmaceuticals
Sanofi
AML
Novartis
Astex Pharmaceuticals announces positive clinical data for SGI-110
The Fly on the Wall
Tue, 04/3/12 - 08:53 am
SGI-110
Astex
AML
acute myeloid leukemia
Major FDA Approval Could Pave the Way for These 5 Biotechs
Seeking Alpha
Thu, 03/31/11 - 11:55 am
FDA
rindopepimut
brain cancer
Celldex
Geron
AML
GRNVAC1
blinatumomab
Micromet
non-Hodgkin's lymphoma
acute lymphoblastic leukemia
Oncothyreon
Stimuvax
breast cancer
lung cancer
Allovectin-7
Vical
melanoma
Should FDA Hit The Brakes On Accelerated Approval?
Pharmalot
Wed, 02/9/11 - 11:54 am
FDA
Roche
Avastin
breast cancer
Pfizer
AML
FDA, Genzyme Spar in Cancer Drug Review
TheStreet.com
Tue, 09/1/09 - 09:57 am
FDA
Genzyme
cancer
AML
Clolar
Genzyme's Clolar Could Face Delay
Yahoo/Zacks.com
Mon, 08/31/09 - 12:02 pm
Clolar
Genzyme
AML
Vion Pharmaceuticals' Onrigin: Good Chance of FDA Approval
Seeking Alpha
Wed, 08/26/09 - 10:21 am
Vion Pharmaceuticals
FDA
Onrigin
AML
Vion files new drug application for leukemia drug
Pharmaceutical Business Review
Thu, 02/19/09 - 06:13 am
Vion Pharmaceuticals
FDA
leukemia
Onrigin
AML
NDA

Pages